IL40833A - Derivatives of 1-amino-3-phenoxypropan-2-ol - Google Patents

Derivatives of 1-amino-3-phenoxypropan-2-ol

Info

Publication number
IL40833A
IL40833A IL40833A IL4083372A IL40833A IL 40833 A IL40833 A IL 40833A IL 40833 A IL40833 A IL 40833A IL 4083372 A IL4083372 A IL 4083372A IL 40833 A IL40833 A IL 40833A
Authority
IL
Israel
Prior art keywords
phenoxypropan
derivatives
amino
Prior art date
Application number
IL40833A
Other languages
English (en)
Other versions
IL40833A0 (en
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of IL40833A0 publication Critical patent/IL40833A0/xx
Publication of IL40833A publication Critical patent/IL40833A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL40833A 1971-12-14 1972-11-14 Derivatives of 1-amino-3-phenoxypropan-2-ol IL40833A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00207954A US3857891A (en) 1971-12-14 1971-12-14 New aminoalkanol compounds and methods for their production

Publications (2)

Publication Number Publication Date
IL40833A0 IL40833A0 (en) 1973-01-30
IL40833A true IL40833A (en) 1976-01-30

Family

ID=22772656

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40833A IL40833A (en) 1971-12-14 1972-11-14 Derivatives of 1-amino-3-phenoxypropan-2-ol

Country Status (21)

Country Link
US (1) US3857891A (fi)
JP (1) JPS5233621B2 (fi)
AR (2) AR195896A1 (fi)
AT (1) AT317182B (fi)
AU (1) AU475446B2 (fi)
BE (1) BE790165A (fi)
CA (1) CA993889A (fi)
CH (1) CH551371A (fi)
DK (1) DK134906B (fi)
ES (1) ES409565A1 (fi)
FI (1) FI55650C (fi)
FR (1) FR2163486B1 (fi)
GB (1) GB1344976A (fi)
HU (1) HU164953B (fi)
IE (1) IE37701B1 (fi)
IL (1) IL40833A (fi)
NL (1) NL150101B (fi)
NO (1) NO135244C (fi)
SE (1) SE393104B (fi)
YU (2) YU35871B (fi)
ZA (1) ZA727078B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119843B1 (fi) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5653534B2 (fi) * 1973-10-25 1981-12-19
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
JPS56158868A (en) * 1980-05-13 1981-12-07 Satake Eng Co Ltd Ion nitriding treatment device
ZA852843B (en) * 1984-05-15 1985-11-27 Warner Lambert Co Bevantolol preparation
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4789751A (en) * 1985-10-01 1988-12-06 University Patents, Inc. Synthesis of new liquid crystal materials possessing phenylbenzoate or biphenyl core units and (2,3)-epoalkyloxirane methanol chiral tails
JP2587336B2 (ja) * 1991-10-03 1997-03-05 日本ケミファ株式会社 塩酸ベバントロールの製造方法
US5482964A (en) * 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
TW467881B (en) * 1997-07-31 2001-12-11 Ying-Jiun Chen Guaiacoxypropanolamines with Α/β-adrenergic blocking activity
AU8527798A (en) * 1998-07-23 2000-02-14 Ing-Jun Chen Guaiacoxypropanolamine derivatives with alpha/beta-adrenergic blocking activity
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
JP4901474B2 (ja) 2003-05-30 2012-03-21 ランバクシー ラボラトリーズ リミテッド 置換ピロール誘導体
CN1884251B (zh) * 2005-06-22 2010-06-23 北京德众万全医药科技有限公司 一种盐酸贝凡洛尔的精制方法
KR101329112B1 (ko) 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
KR102254542B1 (ko) * 2013-06-19 2021-05-24 솜 이노베이션 바이오테크, 에스.엘. 과다운동성 운동 장애의 예방 및/또는 치료에 사용하기 위한 치료제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (fi) * 1962-11-23
NL301580A (fi) * 1962-12-11
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
YU301972A (en) 1981-02-28
JPS4867232A (fi) 1973-09-13
US3857891A (en) 1974-12-31
NL7216281A (fi) 1973-06-18
HU164953B (fi) 1974-05-28
AT317182B (de) 1974-08-12
CA993889A (en) 1976-07-27
AU475446B2 (en) 1976-08-26
FR2163486B1 (fi) 1976-03-05
AR195896A1 (es) 1973-11-15
DE2259489A1 (de) 1973-07-05
NO135244B (fi) 1976-11-29
YU293979A (en) 1981-04-30
ES409565A1 (es) 1975-12-01
GB1344976A (en) 1974-01-23
IE37701B1 (en) 1977-09-28
FI55650C (fi) 1979-09-10
JPS5233621B2 (fi) 1977-08-30
BE790165A (fr) 1973-02-15
AU4918672A (en) 1974-05-23
AR198442A1 (es) 1974-06-21
FI55650B (fi) 1979-05-31
CH551371A (fr) 1974-07-15
IE37701L (en) 1973-05-14
IL40833A0 (en) 1973-01-30
ZA727078B (en) 1973-06-27
DE2259489B2 (de) 1976-02-26
DK134906B (da) 1977-02-07
YU35871B (en) 1981-08-31
DK134906C (fi) 1977-06-27
YU36007B (en) 1981-11-13
NO135244C (fi) 1977-03-09
SE393104B (sv) 1977-05-02
FR2163486A1 (fi) 1973-07-27
NL150101B (nl) 1976-07-15

Similar Documents

Publication Publication Date Title
IL38605A0 (en) P-methane-carboxamide derivatives
HK34278A (en) Derivatives of 17alpha-hydroxy-androst-4ene-17beta-carboxylic acids
IE36079B1 (en) Benzazine derivatives
CY980A (en) 3-substituted-morphinan derivatives
IL40833A (en) Derivatives of 1-amino-3-phenoxypropan-2-ol
KE2731A (en) Oxidazolone derivatives
ZA728312B (en) Isiondoline derivatives
ZA721334B (en) Novel imidazo-pyridine derivatives
IL39880A0 (en) 2-nitro-5-imidazolaldehyde derivatives
IL38936A0 (en) Lumilysergol derivatives
CY908A (en) Triazolyl-ethenyl-phenylene derivatives
GB1408201A (en) Adenosine-5-carboxylate derivatives
GB1401285A (en) Derivatives of alpha-aminocephalosporins
GB1402325A (en) Dibenzoxirenoazepine derivatives
IE37196L (en) Diphenylpyrazolium derivatives
AU5969373A (en) Preparation of derivatives of 5-hydroxy-2-carboxychromone
IL39343A0 (en) The preparation of 4-hydroxy-benzodioxole derivatives
IL39834A (en) Beta-phenyl-beta-fluoroethane derivatives
ZA721356B (en) Benzodiazane derivatives
IL39481A (en) Derivatives of 9-oxo-13-trans-prostenoic acid
ZA725043B (en) New derivatives of dibenzodioxepine
ZA722426B (en) Novel aminophenylketone derivatives
GB1401806A (en) Methylene-dioxyquinazoline derivatives
MY7900211A (en) 2-aminomethylphenol derivatives
JPS5581864A (en) Manufacture of 55fluorouracil derivative